Marex (MRX) Cash & Equivalents (2022 - 2026)

Marex (MRX) has reported Cash & Equivalents for 5 consecutive years, with $3.1 billion the latest figure, recorded in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $3.1 billion, up 17.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.1 billion (up 17.73% YoY), and the FY2025 annual result was $2.9 billion, up 12.7% from the prior year.
• Cash & Equivalents was $3.1 billion for Q1 2026 at Marex, up from $2.9 billion in the prior quarter.
• Over five years, Cash & Equivalents peaked at $3.4 billion in Q2 2025 and troughed at $910.1 million in Q4 2022.
• Average Cash & Equivalents over 5 years is $2.4 billion, with a median of $2.6 billion recorded in 2025.
• The widest YoY moves for Cash & Equivalents: up 76.33% in 2025, down 12.7% in 2025.
• Over 5 years, Cash & Equivalents stood at $910.1 million in 2022, then soared by 63.0% to $1.5 billion in 2023, then soared by 72.34% to $2.6 billion in 2024, then grew by 12.7% to $2.9 billion in 2025, then grew by 6.51% to $3.1 billion in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $3.1 billion in Q1 2026, $2.9 billion in Q4 2025, and $3.1 billion in Q3 2025.